
1. plos pathog. 2010 apr 29;6(4):e1000869. doi: 10.1371/journal.ppat.1000869.

multilayered mechanism cd4 downregulation hiv-1 vpu involving distinct er
retention erad targeting steps.

magadán jg(1), pérez-victoria fj, sougrat r, ye y, strebel k, bonifacino js.

author information: 
(1)cell biology metabolism program, eunice kennedy shriver national institute
of child health human development, national institutes health, bethesda,
maryland, united states america.

a key function vpu protein hiv-1 targeting newly-synthesized 
cd4 proteasomal degradation. function proposed occur a
mechanism fundamentally distinct cellular er-associated
degradation (erad) pathway. however, using combination genetic, biochemical 
and morphological methodologies, find cd4 degradation induced vpu is
dependent key component erad machinery, vcp-ufd1l-npl4 complex,
as well scf(beta-trcp)-dependent ubiquitination cd4 cytosolic tail
on lysine serine/threonine residues. degradation cd4 blocked by
either inactivation vcp-ufd1l-npl4 complex prevention cd4
ubiquitination, vpu still retains bulk cd4 er mainly through
transmembrane domain interactions. addition strong er export signal the
vsv-g protein overrides retention. thus, vpu exerts two distinct activities 
in process downregulating cd4: er retention followed targeting late 
stages erad. multiple levels vpu engages cellular quality
control mechanisms underscore importance ensuring profound suppression 
cd4 life cycle hiv-1.

doi: 10.1371/journal.ppat.1000869 
pmcid: pmc2861688
pmid: 20442859  [indexed medline]

